ADVANCED LUNG CANCER
Standard of care in NSCLC requires testing for ALK, BRAF, EGFR, ERBB2, KRAS, MET, NTRK, RET, ROS1.
Download Study
Pre-treatment imaging
Post-treatment imaging
*Representative patient images
Patient Case
Clinical presentation
- 68-year-old male non-smoker initially presented with severe cough and nausea
- Evaluation showed lung mass, and subsequent PET scan identified multiple metastatic lesions; patient was diagnosed with advanced NSC
Testing
- While waiting for single-gene tissue testing results to be returned, guideline-recommended genomic testing with Guardant360® LDT liquid biopsy identified BRAF V600E in 7 days
Treatment
- The patient was put on BRAF/MET inhibitor combination and achieved a partial response
You might also be interested in
Advanced Breast Cancer
Standard of care testing for BRCA1/2, ERBB2 (HER2), MSI, ESR1, NTRK1/2/3, and PIK3CA.
